Decreased paraoxonase activity in critically ill patients with sepsis
Language English Country Italy Media print-electronic
Document type Journal Article, Research Support, Non-U.S. Gov't
- MeSH
- Aryldialkylphosphatase blood MeSH
- Biomarkers MeSH
- C-Reactive Protein analysis MeSH
- Cholesterol blood MeSH
- Adult MeSH
- Cholesterol, HDL blood MeSH
- Critical Illness * MeSH
- Middle Aged MeSH
- Humans MeSH
- Aged MeSH
- Sepsis diagnosis pathology MeSH
- Check Tag
- Adult MeSH
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Aged MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Names of Substances
- Aryldialkylphosphatase MeSH
- Biomarkers MeSH
- C-Reactive Protein MeSH
- Cholesterol MeSH
- Cholesterol, HDL MeSH
- PON1 protein, human MeSH Browser
Paraoxonase 1 is believed to play a role in preventing lipid oxidation and, thus, limiting production of proinflammatory mediators. Systemic inflammatory response in sepsis increases oxidative stress and decreases high-density lipoprotein (HDL) concentrations. The objective of this study was to investigate serum paraoxonase 1 activities in critically ill patients with sepsis and after recovery. Serum paraoxonase 1 arylesterase/paraoxonase activities, concentration of total cholesterol, HDL cholesterol (HDL-C) and serum C-reactive protein (CRP) in septic patients of a medical intensive care unit (n = 30) and age/sex-matched outpatient controls without sepsis (n = 30) were analyzed. Paired convalescent samples were also taken 1 week after recovery (n = 11). In septic patients, both arylesterase (88.3 +/- 36.5 vs. 162.1 +/- 44.8 kU/l, P < 0.001) and paraoxonase (75.2 +/- 50.0 vs. 125.2 +/- 69.4 U/l, P < 0.01) paraoxonase 1 activities decreased as compared to controls. Both activities normalized after recovery. Negative correlation was found between CRP and both arylesterase (r = -0.676, P < 0.001) and paraoxonase (r = -0.401, P < 0.01) as well as positive correlation between HDL-C and both arylesterase (r = 0.585, P < 0.001) and paraoxonase (r = 0.405, P < 0.01) paraoxonase 1 activities. The decreased activity of paraoxonase 1 in negative correlation with CRP offers a potentially useful marker of sepsis progress and recovery in critically ill patients.
See more in PubMed
Am J Hum Genet. 1983 Nov;35(6):1126-38 PubMed
Crit Care Med. 2003 May;31(5):1359-66 PubMed
Atherosclerosis. 2007 Sep;194(1):175-81 PubMed
Scand J Immunol. 1998 Oct;48(4):419-24 PubMed
Inflamm Bowel Dis. 2009 Jan;15(1):93-9 PubMed
Atherosclerosis. 1998 Aug;139(2):307-15 PubMed
Crit Care Med. 1985 Oct;13(10):818-29 PubMed
Crit Care Clin. 2000 Apr;16(2):179-92 PubMed
Clin Chem. 1986 Jan;32(1 Pt 1):142-5 PubMed
Shock. 2003 Sep;20(3):208-12 PubMed
J Clin Invest. 1995 Dec;96(6):2758-67 PubMed
Atherosclerosis. 2006 Jun;186(2):396-401 PubMed
Atherosclerosis. 2008 Jan;196(1):270-274 PubMed
Free Radic Biol Med. 2004 Dec 15;37(12):1986-94 PubMed
Clin Chem. 1986 Apr;32(4):671-3 PubMed
J Clin Invest. 1995 Dec;96(6):2882-91 PubMed
Shock. 2004 Mar;21(3):210-21 PubMed
Biochemistry. 2005 Sep 6;44(35):11843-54 PubMed
J Nephrol. 2004 Nov-Dec;17(6):813-8 PubMed
J Lipid Res. 2005 Mar;46(3):389-403 PubMed
EMBO J. 1989 Dec 1;8(12):3773-9 PubMed
Chest. 1992 Jun;101(6):1644-55 PubMed
Altered activities of antioxidant enzymes in patients with metabolic syndrome
